Cartesian Therapeutics
RNAC
#6732
Rank
โ‚น39.78 B
Marketcap
โ‚น1,665
Share price
3.61%
Change (1 day)
-39.33%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -โ‚น20.6 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are โ‚น54.1 Million. In 2023 the company made an earning of -โ‚น19.84 Billion a decrease over its 2022 earnings that were of โ‚น3.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น20.6 Billion3.85%
2023 -โ‚น19.84 Billion-724%
2022 โ‚น3.17 B-649.67%
2021 -โ‚น0.58 Billion-89.78%
2020 -โ‚น5.67 Billion25.06%
2019 -โ‚น4.53 Billion-15.68%
2018 -โ‚น5.37 Billion-0.43%
2017 -โ‚น5.4 Billion83.41%
2016 -โ‚น2.94 Billion44.3%
2015 -โ‚น2.04 Billion